What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study

Neurology

Volumn 49, Issue 1, 1997, Pages 62-69

  Litvan, I ^a   Agid, Y ^b   Sastrj, N ^a   Jankovic, J ^c   Wenning, G K ^d,k   Goetz, C G ^e   Verny, M ^b   Brandel, J P ^b   Jellinger, K ^f   Chaudhuri, R ^g   McKee, A ^h   Lai, E C ^c   Pearce, R K B ⁱ   Bartko, J J ^j  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e RUSH MEDICAL COLLEGE   (United States)

^f LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ Institute of Neurology   (United Kingdom)

^j NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^k UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

EID: 18144450386     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.1.62     Document Type: Article

References (65)

1. Pick A. Uber einen weiteren Symptomencomplex im Rahmen der Dementia senilis, bedingt durch umschriebene starkere Hirnatrophie (gemischte Apraxie). Monatsschrift Psychiatr Neurol 1906;19:97-108.
2. Kertesz A, Kalvach P. Arnold Pick and German neuropsychiatry in Prague. Arch Neurol 1996;53:935-938.
3. Alzheimer A. Uber eigenartige Krankheitsfalle des spateren Alters. Zeitschrift Ges Neurol Psychiatr 1911;4:356-385.
4. Constantinidis J, Richard J, Tissot R. Pick's disease histological and clinical correlations. Eur Neurol 1974;11:208-217.
5. Tissot R, Constantinidis J, Richard J. Pick's disease. In: Frederiks JAM, ed. Handbook of clinical neurology. Amsterdam: Elsevier, 1985.
6. Gustafson L. Frontal lobe degeneration of non-Alzheimer's type. Acta Gerontol Geriatr 1987;6:209-223.
7. Neary D, Snowden J, Northern B, Goulding P. Dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 1988;51: 353-361.
8. Brown J. Pick's disease. Baillieres Clin Neurol 1992;1:535-557.
9. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
10. Jellinger KA. Neuropathologic criteria for Pick's disease and frontotemporal lobe dementia. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, eds. Neuropathological diagnostic criteria for brain banking. Amsterdam: IOS Press, 1995:35-54.
11. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44: 2015-2019.
12. Kosaka K, Ikeda K, Kobayashi K, Mehraein P. Striatopallidonigral degeneration in Pick's disease: a clinicopathologic study of 41 cases. J Neurol 1991;238:151-160.
13. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996;91:127-134.
14. Brun A. Frontal lobe degeneration of non-Alzheimer's type. Arch Gerontol Geriatr 1987;6:193-208.
15. Knopman DS. Overview of dementia lacking distinctive histology. Dementia 1993;4:132-136.
16. Kertesz A. Pick complex and Pick's disease: the nosology of frontal lobe dementia, primary progressive aphasia, and corticobasal ganglionic degeneration. Eur J Neurol 1996;3:280-282.
17. Duyckaerts C, Durr A, Uchihara T, Boller F, Hauw JJ. Pick complex: too simple? Eur J Neurol 1996;3:283-286.
18. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
19. Mendez M, Selwood A, Mastri A, Frey W. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology 1993;43:289-292.
20. Tierney M, Fisher R, Lewis A, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-364.
21. Boller F, Lopez OL, Moossy J. Diagnosis of dementia: clinicopathologic correlations. Neurology 1989;39:76-79.
22. Kukull WA, Larson EB, Reifler BV, et al. The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology 1990;40:1364-1369.
23. Kukull WA, Larson EB, Reifler BV, Lampe TH, Yerby M, Hughes J. Interrater reliability of Alzheimer's disease diagnosis. Neurology 1990;40:257-260.
24. Lopez OL, Swihart AA, Becker JT, et al. Reliability of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. Neurology 1990;40:1517-1522.
25. Mendez MF, Mastri AR, Sung JH, Zander BA, Frey WH. Neuropathologically confirmed Alzheimer's disease: clinical diagnoses in 394 cases. J Geriatr Psychiatr Neurol 1991;4:26-29.
26. DeKosky ST, Harbaugh RE, Schmitt FA, et al. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 1992;32:625-632.
27. Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995; 152:1476-1484.
28. Klatka LA, Schiffer RB, Powers JM, Kazee AM. Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. Arch Neurol 1996;53:35-42.
29. Kosunen O, Soininen H, Paljarvi L, Heinonen O, Talasniemi S, Riekkinen PJS. Diagnostic accuracy of Alzheimer's disease: a neuropathological study. Acta Neuropathol (Berl) 1996;91: 185-193.
30. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.
31. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
32. Litvan I, Agid Y, Goetz C, et al. Accuracy of clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology 1997;48:119-125.
33. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
34. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204.
35. Galen S, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: John Wiley & Sons, 1975.
36. SAS Institute Inc. SAS procedures guide. Cary, NC, 1990.
37. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981.
38. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
39. SAS Institute Inc. JMP statistics and graphics guide. Cary, NC, 1994.
40. Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: American Psychiatric Association, 1994.
41. Jellinger KA. Structural basis of dementia in neurodegenerative disorders. In: Jellinger KA, Windisch M, eds. New trends in the diagnosis and therapy of non-Alzheimer's dementia. Vienna: Springer, 1996:1-29.
42. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47:1184-1189.
43. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994;57:7988.
44. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115:1727-1751.
45. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991;41:634-643.
46. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986;36: 1179-1185.
47. Levy ML, Miller BL, Cummings JL, Fairbanks LA, Craig A. Alzheimer disease and frontotemporal dementias. Arch Neurol 1996;53:687-690.
48. Kertesz A, Hudson L, Mackenzie IR, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology 1994;44:2065-2072.
49. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-620.
50. Nuwer M. Progressive supranuclear palsy despite normal eye movements. Arch Neurol 1981;38:784.
51. Daniel SE, De Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118: 759-770.
52. Binetti G, Locascio JJ, Corkin S, Growdon JH. Pick's disease and Alzheimer's disease have different cognitive profiles [abstract]. Soc Neurosci 1996;22:15.
53. Lang AE, Riley DE, Bergeron C. Cortical-basal ganglionic degeneration. In: Calne DB, ed. Neurodegenerative diseases. Philadelphia: WB Saunders, 1994;877-894.
54. Watts RL, Mirra SS, Richardson EP. Cortical-basal ganglionic degeneration. Oxford: Butterworth Heinemann, 1994.
55. Lennox G, Jackson M, Lowe J. Corticobasal degeneration manifesting as a frontal lobe dementia. Ann Neurol 1994;36: 273-274.
56. Oda T, Ikeda K, Akamatus W, et al. An autopsy case of corticobasal degeneration clinically misdiagnosed as Pick's disease. Seishin Shinkeigaku Zasshi 1995;97:757-769.
57. Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436-1440.
58. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994;117: 1183-1196.
59. Miller BL, Ikonte C, Ponton M, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and SPECT correlations. Neurology 1997;48:937-942.
60. Cummings JL, Duchen LW. Kluver-Bucy syndrome in Pick's disease: clinical and pathologic correlations. Neurology 1981; 31:1415-1422.
61. Weinstein H, Hijdra A, van Royen E, Derix M. Determination of cerebral blood flow by SPECT: a valuable tool in the investigation of dementia? Clin Neurol Neurosurg 1989;91:13-19.
62. Salmon E, Franck G. Positron emission tomographic study in Alzheimer's disease and Pick's disease. Arch Gerontol Geriatr Suppl 1989;1:241-247.
63. Habert MO, Spampinato U, Mas JL, et al. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. Eur J Nucl Med 1991;18: 3-11.
64. Friedland RP, Koss E, Lerner A, et al. Functional imaging, the frontal lobes, and dementia. Dementia 1993;4:192-203.
65. Kaufer DI, Miller BL, Itti L, et al. Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology 1997;48:978-984.